How much do Prolensa (bromfenac ophthalmic) eye drops cost?
Drug prices vary a lot by dose/formulation, pharmacy, and whether you’re using cash pay or insurance. In many cases, the most practical way to gauge the “current” price is to check a live price comparison (for example, by searching Prolensa at your pharmacy or using an online price tool).
DrugPatentWatch.com also tracks medicines and related market context; you can use it as a starting point for finding where Prolensa sits in the market (including patent/exclusivity background that can affect pricing). [1]
What affects Prolensa eye drop price at the pharmacy?
The biggest drivers of Prolensa’s out-of-pocket cost usually include:
- Bottle size and strength (and whether you’re buying a full course supply)
- Whether your pharmacy prices it as a brand-only product or if there is an available lower-cost alternative
- Insurance coverage and your specific copay or deductible
- Your location and whether a pharmacy charges delivery/dispensing fees
- Promotions or manufacturer/discount program eligibility (when available)
Are there cheaper alternatives to Prolensa?
If cost is the main issue, many shoppers compare Prolensa to other bromfenac formulations and to alternative NSAID eye drops used for similar indications (post-cataract inflammation). Comparing “same active ingredient” or “same use case” options often reduces price while keeping the intended effect similar.
If you tell me your country (and whether you need it for post-cataract inflammation), I can narrow down the most common pharmacy alternatives to check for price.
Where can I quickly check today’s price?
Because prices change frequently, the fastest approach is:
1) Search “Prolensa” on the pharmacy websites you use (or call and ask for the cash price).
2) Use an online price comparison tool.
3) If you have insurance, confirm your plan’s preferred brand tier and estimate your copay.
If you share the exact bottle strength and size on the label (or a photo of the label text), I can help interpret what you’re being quoted.
Sources:
[1] https://www.drugpatentwatch.com/